Drug Importation

Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Blog

The Fentanyl Resurgimiento— A Drug Like No Other

On January 11, 2023, Dr. Rahul Gupta, the Director of the White House Office of National Drug Control Policy (ONDCP) declared a small victory. He reported new figures from the Center for Disease Control estimating that nationally there was a 2.57 percent decrease in the number of fatal drug overdoses for ...
Commentary

Diversifying America’s supply chains point to a more prosperous economic future

Rep. Cathy McMorris Rodgers, R-Wash., the chair of the powerful House Energy and Commerce Committee, recently warned that the United States is “dangerously dependent” on Chinese supply chains, especially for the raw materials used to make medicines. Her statement reflects the genuine worries of industry experts and ordinary Americans. If ...
Commentary

What Is the Value of the Interchangeability Designation for a Biosimilar?

By Wayne Winegarden, Robert Popovian & Peter Pitts Biosimilars, to date, have achieved the promise of reducing prices and drug spending in the United States. The unquestioned safety and efficacy of biosimilars have given providers, patients, and employers, amongst many others, the confidence that savings will be even more robust as we ...
Commentary

The FDA and Death by Dietary Supplement

The wife of California Republican congressman Tom McClintock, Lori McClintock, died of dehydration due to gastroenteritis caused by “adverse effects of white mulberry leaf ingestion,” according to a just-released coroner’s report. That herb is just one of many dubious and potentially life-threatening herbal remedies and other dietary supplements on the market ...
Commentary

Don’t Fall Prey to Five Common Healthcare Myths

  President-elect Barack Obama has promised to make healthcare reform a top priority. But in order to follow through, Obama and lawmakers on Capitol Hill must reject some longstanding misconceptions about health care in this country. Here are five such myths. Each is widely repeated, deeply held – and dead ...
Commentary

Drug Importation Doesn’t Save Money — It Costs Lives

Proponents of prescription-drug importation notched a victory last week. The Senate Health, Education, Labor, and Pensions Committee green-lit a bill that would enable individuals to import medicines from Canada in the name of lowering out-of-pocket costs. It’s not something Americans should welcome or support. Drugs imported from outside the United States will ...
Commentary

Drug Importation Programs Come At Too High a Cost

Lawmakers in Colorado are trying to open their state’s borders to prescription drugs from abroad. In 2019, they green-lit imports from Canada. They’re still working on a plan to implement that policy that can garner federal approval. Then last week, legislators approved a bill that would allow Coloradans to import prescription drugs ...
Drug Importation

NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
Drug Importation

New Animated Series Aims to Help Patients “Escape the Drug Pricing Maze”

SAN FRANCISCO – As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched today by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing ...
Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Blog

The Fentanyl Resurgimiento— A Drug Like No Other

On January 11, 2023, Dr. Rahul Gupta, the Director of the White House Office of National Drug Control Policy (ONDCP) declared a small victory. He reported new figures from the Center for Disease Control estimating that nationally there was a 2.57 percent decrease in the number of fatal drug overdoses for ...
Commentary

Diversifying America’s supply chains point to a more prosperous economic future

Rep. Cathy McMorris Rodgers, R-Wash., the chair of the powerful House Energy and Commerce Committee, recently warned that the United States is “dangerously dependent” on Chinese supply chains, especially for the raw materials used to make medicines. Her statement reflects the genuine worries of industry experts and ordinary Americans. If ...
Commentary

What Is the Value of the Interchangeability Designation for a Biosimilar?

By Wayne Winegarden, Robert Popovian & Peter Pitts Biosimilars, to date, have achieved the promise of reducing prices and drug spending in the United States. The unquestioned safety and efficacy of biosimilars have given providers, patients, and employers, amongst many others, the confidence that savings will be even more robust as we ...
Commentary

The FDA and Death by Dietary Supplement

The wife of California Republican congressman Tom McClintock, Lori McClintock, died of dehydration due to gastroenteritis caused by “adverse effects of white mulberry leaf ingestion,” according to a just-released coroner’s report. That herb is just one of many dubious and potentially life-threatening herbal remedies and other dietary supplements on the market ...
Commentary

Don’t Fall Prey to Five Common Healthcare Myths

  President-elect Barack Obama has promised to make healthcare reform a top priority. But in order to follow through, Obama and lawmakers on Capitol Hill must reject some longstanding misconceptions about health care in this country. Here are five such myths. Each is widely repeated, deeply held – and dead ...
Commentary

Drug Importation Doesn’t Save Money — It Costs Lives

Proponents of prescription-drug importation notched a victory last week. The Senate Health, Education, Labor, and Pensions Committee green-lit a bill that would enable individuals to import medicines from Canada in the name of lowering out-of-pocket costs. It’s not something Americans should welcome or support. Drugs imported from outside the United States will ...
Commentary

Drug Importation Programs Come At Too High a Cost

Lawmakers in Colorado are trying to open their state’s borders to prescription drugs from abroad. In 2019, they green-lit imports from Canada. They’re still working on a plan to implement that policy that can garner federal approval. Then last week, legislators approved a bill that would allow Coloradans to import prescription drugs ...
Drug Importation

NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
Drug Importation

New Animated Series Aims to Help Patients “Escape the Drug Pricing Maze”

SAN FRANCISCO – As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched today by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing ...
Scroll to Top